SCHEMBL19082225

SCHEMBL19082225

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5sc6ccccc6c5c5c4sc4ccc6ccccc6c45)cc3)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.38
CHEK1 O14757 1/20 0.37
WEE1 P30291 1/20 0.37
NQO2 P16083 2/20 0.36
NQO1 P15559 1/20 0.36
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
DUSP3 P51452 2/20 0.34
PTPRC P08575 1/20 0.34
PTPRF P10586 1/20 0.34
PTPRA P18433 1/20 0.34
PTPRB P23467 1/20 0.34
PTPN6 P29350 1/20 0.34
PTPN12 Q05209 1/20 0.34
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082157 0.94 PTPN1 (0.37) PTPN1CHEK1WEE1NQO2NQO1
SCHEMBL19082295 0.93 PTPN1 (0.36) PTPN1CHEK1WEE1NQO2NQO1
SCHEMBL17932225 0.88 PTPN1 (0.40) PTPN1CHEK1WEE1DUSP3PTPRC
SCHEMBL19080222 0.87 CHEK1 (0.39) CHEK1WEE1NQO2NQO1KDM4E
SCHEMBL17945062 0.85 PTPN1 (0.36) PTPN1CHEK1WEE1NQO2NQO1
SCHEMBL17945084 0.85 ALOX5 (0.36) PTPN1CHEK1WEE1DUSP3PTPRC
SCHEMBL24614702 0.84 PTPN1 (0.34) PTPN1CHEK1WEE1NQO2NQO1
SCHEMBL17944201 0.84 ALOX5 (0.39) PTPN1CHEK1WEE1NQO2NQO1
SCHEMBL19082229 0.84 NQO2 (0.36) PTPN1CHEK1WEE1NQO2NQO1
SCHEMBL19077270 0.83 CHEK1 (0.42) PTPN1CHEK1WEE1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PTPN1 4695/4885CHEK1 255/4885WEE1 683/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PTPN1 4695/4885CHEK1 255/4885WEE1 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.